PL2121689T3 - Spirocykliczne pochodne cykloheksanu - Google Patents

Spirocykliczne pochodne cykloheksanu

Info

Publication number: PL2121689T3
Authority: PL; Poland
Prior art keywords: cyclohexane derivatives; spirocyclic cyclohexane; spirocyclic; derivatives; cyclohexane
Prior art date: 2007-02-22

Application number

PL08707767T

Other languages

English (en)

Inventor

Stefan Schunk

Saskia Zemolka

Derek Saunders

Michael Gruss

Heinz Graubaum

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-02-22

Filing date

2008-02-19

Publication date

2013-12-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39535309&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2121689(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-02-19 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2013-12-31 Publication of PL2121689T3 publication Critical patent/PL2121689T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Addiction (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Obesity (AREA)
Child & Adolescent Psychology (AREA)
Gynecology & Obstetrics (AREA)
Anesthesiology (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PL08707767T 2007-02-22 2008-02-19 Spirocykliczne pochodne cykloheksanu PL2121689T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE102007009235A DE102007009235A1 (de)	2007-02-22	2007-02-22	Spirocyclische Cyclohexan-Derivate
EP08707767.3A EP2121689B1 (de)	2007-02-22	2008-02-19	Spirocyclische cyclohexan-derivate
PCT/EP2008/001270 WO2008101659A1 (de)	2007-02-22	2008-02-19	Spirocyclische cyclohexan-derivate

Publications (1)

Publication Number	Publication Date
PL2121689T3 true PL2121689T3 (pl)	2013-12-31

Family

ID=39535309

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08707767T PL2121689T3 (pl)	2007-02-22	2008-02-19	Spirocykliczne pochodne cykloheksanu

Country Status (18)

Country	Link
US (1)	US8404740B2 (pl)
EP (1)	EP2121689B1 (pl)
JP (1)	JP5366832B2 (pl)
KR (1)	KR101515795B1 (pl)
CN (1)	CN101622255B (pl)
AU (1)	AU2008217276B2 (pl)
BR (1)	BRPI0806796A2 (pl)
CA (1)	CA2679166C (pl)
DE (1)	DE102007009235A1 (pl)
EC (1)	ECSP099620A (pl)
ES (1)	ES2433205T3 (pl)
IL (1)	IL200497A (pl)
MX (1)	MX2009008781A (pl)
NZ (1)	NZ578717A (pl)
PL (1)	PL2121689T3 (pl)
RU (1)	RU2484092C2 (pl)
WO (1)	WO2008101659A1 (pl)
ZA (1)	ZA200906585B (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102006033114A1 (de) *	2006-07-18	2008-01-24	Grünenthal GmbH	Spirocyclische Azaindol-Derivate
CA2727055C (en)	2008-01-11	2016-12-20	Albany Molecular Research, Inc.	(1-azinone) -substituted pyridoindoles as mch antagonists
PE20091822A1 (es)	2008-03-27	2009-12-10	Gruenenthal Chemie	Hidroximetilciclohexilaminas
RU2532545C2 (ru)	2008-03-27	2014-11-10	Грюненталь Гмбх	Замещенные производные 4-аминоциклогексана
CN102083790B (zh)	2008-03-27	2014-03-05	格吕伦塔尔有限公司	螺(5.5)十一烷衍生物
SI2260042T1 (sl)	2008-03-27	2011-11-30	Gruenenthal Gmbh	Substituirani spirociklični cikloheksanski derivati
TWI466866B (zh)	2008-03-27	2015-01-01		被取代之環己基二胺
WO2011003007A1 (en)	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
EP2448585B1 (en)	2009-07-01	2014-01-01	Albany Molecular Research, Inc.	Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
WO2011003012A1 (en)	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
WO2011003021A1 (en)	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
DK2600839T3 (da) *	2010-08-04	2018-01-29	Gruenenthal Gmbh	Farmaceutisk doseringsform omfattende 6'-fluoro-(n-methyl- eller n,n-dimethyl-)-4-phenyl-4',9'-dihydro-3'h-spiro[cylohexan-1,1'-pyrano[3,4,b]indol]-4-amin
PT2649044T (pt)	2010-12-08	2017-12-07	Gruenenthal Gmbh	Método para síntese de derivados de aminociclo-hexanona substituídos
US8993765B2 (en)	2010-12-21	2015-03-31	Albany Molecular Research, Inc.	Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
US8697700B2 (en)	2010-12-21	2014-04-15	Albany Molecular Research, Inc.	Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof
CN102659662A (zh) *	2012-03-28	2012-09-12	华东师范大学	3-r-3-羟基-2-氧化吲哚类化合物的合成方法
PL3110797T3 (pl)	2014-02-27	2019-11-29	Gruenenthal Gmbh	Proces otrzymywania 5-fluorotryptofolu
TW201607923A (zh) *	2014-07-15	2016-03-01	歌林達有限公司	被取代之氮螺環（４．５）癸烷衍生物
US10214520B2 (en) *	2014-07-15	2019-02-26	Gruenenthal Gmbh	Substituted azaspiro(4.5)decane derivatives

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1055203A (en)	1964-09-16	1967-01-18	Ici Ltd	-ß-carboline derivatives, a process for their manufacture, and compositions containing them
US4291039A (en)	1980-08-08	1981-09-22	Miles Laboratories, Inc.	Tetrahydro β-carbolines having anti-hypertensive activity
DE3309596A1 (de)	1982-08-05	1984-04-05	Basf Ag, 6700 Ludwigshafen	2-substituierte 1-(3'-aminoalkyl)-1,2,3,4-tetrahydro-ss-carboline, ihre herstellung und verwendung als arzneimittel
US5328905A (en)	1987-07-20	1994-07-12	Duphar International Research B.V.	8,9-anellated-1,2,3,4-tetrahydro-β-carboline derivatives
US5491168A (en) *	1991-08-27	1996-02-13	Uniroyal Chemical Company, Inc.	Synergistic insecticidal compositions
EP0620222A3 (en)	1993-04-14	1995-04-12	Lilly Co Eli	Tetrahydro-beta-carbolines.
US5631265A (en)	1994-03-11	1997-05-20	Eli Lilly And Company	8-substituted tetrahydro-beta-carbolines
US5861408A (en)	1995-05-19	1999-01-19	Eli Lilly And Company	Tetrahydro-Beta-Carbolines
TWI329111B (en)	2002-05-24	2010-08-21	X Ceptor Therapeutics Inc	Azepinoindole and pyridoindole derivatives as pharmaceutical agents
US7595311B2 (en)	2002-05-24	2009-09-29	Exelixis, Inc.	Azepinoindole derivatives as pharmaceutical agents
DE10252667A1 (de)	2002-11-11	2004-05-27	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
US20060235012A1 (en)	2003-06-16	2006-10-19	Chroma Therapeutics Limited	Carboline and betacarboline derivatives for use as hdac enzyme inhibitors
AR045843A1 (es) *	2003-10-03	2005-11-16	Solvay Pharm Bv	Derivados de bencimidazolonas y quinazolinonas sustituidas con hidronopol como agonistas en receptores orl 1 humanos
DE10360793A1 (de) *	2003-12-23	2005-07-28	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
DE10360792A1 (de) *	2003-12-23	2005-07-28	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
WO2006065480A2 (en)	2004-11-23	2006-06-22	Ptc Therapeutics, Inc.	Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control
US7901141B2 (en) *	2005-02-14	2011-03-08	Nsk Ltd.	Hub unit bearing
DE102005016460A1 (de)	2005-04-11	2006-10-19	Grünenthal GmbH	Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
EP1747779A1 (en)	2005-07-28	2007-01-31	Laboratorios Del Dr. Esteve, S.A.	Tetrahydro-b-carbolin-sulfonamide derivatives as 5-HT6 ligands
US20070149557A1 (en)	2005-11-21	2007-06-28	Amgen Inc.	CXCR3 antagonists
DE102006033109A1 (de) *	2006-07-18	2008-01-31	Grünenthal GmbH	Substituierte Heteroaryl-Derivate
DE102006046745A1 (de)	2006-09-29	2008-04-03	Grünenthal GmbH	Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz

2007
- 2007-02-22 DE DE102007009235A patent/DE102007009235A1/de not_active Withdrawn
2008
- 2008-02-19 WO PCT/EP2008/001270 patent/WO2008101659A1/de not_active Ceased
- 2008-02-19 ES ES08707767T patent/ES2433205T3/es active Active
- 2008-02-19 EP EP08707767.3A patent/EP2121689B1/de not_active Not-in-force
- 2008-02-19 KR KR1020097019744A patent/KR101515795B1/ko not_active Expired - Fee Related
- 2008-02-19 JP JP2009550239A patent/JP5366832B2/ja not_active Expired - Fee Related
- 2008-02-19 NZ NZ578717A patent/NZ578717A/en not_active IP Right Cessation
- 2008-02-19 CN CN2008800059845A patent/CN101622255B/zh not_active Expired - Fee Related
- 2008-02-19 MX MX2009008781A patent/MX2009008781A/es active IP Right Grant
- 2008-02-19 RU RU2009135072/04A patent/RU2484092C2/ru not_active IP Right Cessation
- 2008-02-19 CA CA2679166A patent/CA2679166C/en not_active Expired - Fee Related
- 2008-02-19 AU AU2008217276A patent/AU2008217276B2/en not_active Ceased
- 2008-02-19 PL PL08707767T patent/PL2121689T3/pl unknown
- 2008-02-19 BR BRPI0806796-1A patent/BRPI0806796A2/pt active Search and Examination
2009
- 2009-08-20 IL IL200497A patent/IL200497A/en active IP Right Grant
- 2009-08-21 US US12/545,461 patent/US8404740B2/en not_active Expired - Fee Related
- 2009-09-09 EC EC2009009620A patent/ECSP099620A/es unknown
- 2009-09-21 ZA ZA200906585A patent/ZA200906585B/xx unknown

Also Published As

Publication number	Publication date
AU2008217276A1 (en)	2008-08-28
CN101622255B (zh)	2013-12-11
AU2008217276B2 (en)	2012-08-23
WO2008101659A1 (de)	2008-08-28
MX2009008781A (es)	2009-08-24
NZ578717A (en)	2012-03-30
KR101515795B1 (ko)	2015-04-29
ECSP099620A (es)	2009-10-30
US8404740B2 (en)	2013-03-26
EP2121689B1 (de)	2013-07-31
CA2679166A1 (en)	2008-08-28
DE102007009235A1 (de)	2008-09-18
ES2433205T3 (es)	2013-12-09
HK1136828A1 (en)	2010-07-09
JP5366832B2 (ja)	2013-12-11
RU2484092C2 (ru)	2013-06-10
CA2679166C (en)	2016-01-19
IL200497A (en)	2014-02-27
EP2121689A1 (de)	2009-11-25
RU2009135072A (ru)	2011-03-27
US20100048554A1 (en)	2010-02-25
ZA200906585B (en)	2010-06-30
CN101622255A (zh)	2010-01-06
BRPI0806796A2 (pt)	2011-09-13
KR20090129438A (ko)	2009-12-16
IL200497A0 (en)	2010-04-29
JP2010519233A (ja)	2010-06-03

Publication	Publication Date	Title
IL200497A0 (en)	2010-04-29	Spirocyclic cyclohexane derivatives
IL208278A0 (en)	2010-12-30	Substituted spirocyclic cyclohexane derivatives
IL210548A0 (en)	2011-03-31	Spiroaminodihydrothiazine derivatives
ZA201100799B (en)	2011-10-26	Imidazopyridin-2-one derivatives
SG10201506608RA (en)	2015-09-29	3-deazaneplanocin derivatives
ZA201100876B (en)	2011-10-26	Pyrrolopyridinylpyrimidin-2-ylamine derivatives
ZA201102449B (en)	2011-12-28	Morpholinopurine derivatives
IL208336A0 (en)	2010-12-30	Pyrisazinone derivatives
IL210869A0 (en)	2011-04-28	Imidazothiadiazoles derivatives
ZA200904745B (en)	2010-09-29	Spirocyclic tetronic acid derivatives
IL211290A0 (en)	2011-04-28	New 2-amidothiadiazole derivatives
IL210613A0 (en)	2011-03-31	Novel acylaminobenzamide derivatives
IL207192A0 (en)	2010-12-30	Substituted heteroarylamide diazepinopyrimidone derivatives
IL210164A0 (en)	2011-03-31	Thiazolylpiperidine derivatives
ZA201005381B (en)	2011-10-26	Substituted heteroarylamide oxazepinopyrimidone derivatives
IL213424A0 (en)	2011-07-31	Quinazolinamide derivatives
ZA201201473B (en)	2012-11-28	Spirocyclic amide derivatives
ZA201008052B (en)	2012-04-25	2-phenyl-4-cyclopropyl-pyrimidine derivatives
EP2133347A4 (en)	2010-03-17	1-BIARYLAZETIDINONDERIVATE
AU2008100998A4 (en)	2008-12-04	Signalling Specification
IL213051A0 (en)	2011-07-31	Difluorophenyldiacylhydrazide derivatives
HK1171448A (en)	2013-03-28	Spirocyclic amide derivatives
GB0821711D0 (en)	2008-12-31	Dihydroindolone derivatives
GB0816145D0 (en)	2008-10-15	a-Galactosylceramide derivatives
HU0800376D0 (en)	2008-08-28	Sulfonyl-quinoline derivatives